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Abstract
Background: Cancer of the oral cavity is the sixth most common malignancy reported worldwide and one with
the highest mortality rate among all malignancies. There is a paucity of reliable diagnostic methods to detect early
malignancies. This study was performed to evaluate the sensitivity and specificity of brush biopsy in identifying oral
premalignant and malignant lesions.
Methods: Oral brush and scalpel biopsies were performed on 85 consecutive patients presenting with an oral
lesion deemed to be minimally suspicious by clinical examination and the results were compared.
Results: Of 79 patients with adequate brush biopsy samples with matching scalpel biopsies, 27 revealed
histopathologic evidence of dysplasia or carcinoma, 26 of which were independently identified with the oral brush
biopsy (sensitivity: 96.3% - 95% CI, 87%-100%). 52 oral lesions did not reveal any histopathologic evidence of
dysplasia or carcinoma and of these, brush biopsy reported 47 as “negative” and 5 as “atypical"(specificity of
“positive” brush biopsy result is 100%- 95% CI, 93%-100%; specificity for “atypical” brush biopsy result is 90.4%- 95%
CI, 82%-97%. The positive predictive value of an abnormal oral brush biopsy was 84% and the negative predictive
value was 98%.
Conclusion: Our study demonstrated that the oral brush biopsy is an accurate test in identifying oral premalignant
and malignant lesions, even if minimally suspicious.
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Background
Cancer of the oral cavity is the sixth most common malig-
nancy reported worldwide and one with the highest
mortality rate among all malignancies. In 2011, an esti-
mated 34,300 patients developed oral cavity and orophar-
yngeal cancer in the United States, and approximately
6900 died from the disease [1]. In India, oral cancer repre-
sents a major health problem accounting for up to 40% of
all cancers, and is the most prevalent cancer in males and
the third most prevalent cancer in females [2,3]. Joseph
et al. reported that early diagnosis of oral cancer greatly
increases the probability of cure with minimum impair-
ment and deformity [4]. Primary prevention, which
involves adopting a healthy lifestyle and reducing the
exposure to tobacco, alcohol and betel quid has been
s h o w nt ob ee f f e c t i v ei nr e d u c i n gt h ei n c i d e n c eo fo r a l
cancer. Secondary prevention involves detecting and con-
trolling early stage cancer and the precursor stage- dyspla-
sia, when such lesions are easiest to cure [4]. The
implementation of both primary and secondary prevention
programs is essential to reduce the high oral cancer
mortality rate.
One major problem inherent in current oral cancer
screening is that visual inspection often cannot differ-
entiate between lesions harboring dysplasia and/or early
cancer from those that do not. This is especially true for
innocuous looking lesions which are subjected to
“watchful waiting” and close follow-up despite the fact
that some precancerous and cancerous cells within
them remain undetected and are allowed to progress to
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evaluating all suspicious lesions, that is, lesions without
a specific etiology such as trauma or infection, invariably
results in delay of the correct diagnosis, limiting treat-
ment options.
Another obstacle in the early detection of oral cancer
and precancer is the fact that a large proportion of the
population- up to 15%- have an oral lesion [6,7]. Not
only is it impractical to subject all of these lesions to a
surgical biopsy but the procedure itself is associated with
pain and morbidity. Furthermore, when presented with
the need to have an oral biopsy performed, patients are
often understandably reluctant to undergo an invasive
surgical procedure. This may be compounded by the
clinician’s hesitation to perform a surgical procedure in
an unfamiliar anatomical site. Additionally, in US medical
schools and dental schools, training in oral cancer identi-
fication is often inadequate [8], and in one study of senior
dental students at three Texas dental schools, just over
50% had ever observed an oral biopsy and only about
25% had actually performed one [9]. Not surprisingly,
only a quarter of leukoplakias, the most common oral
precancer, are ever subjected to biopsy [10]. Given the
limited value of an oral examination as a method for
detecting precancerous or early cancerous lesions, addi-
tional diagnostic tests are desperately needed.
In contrast to sampling cells of the uterine cervix, analy-
sis of surface epithelial cells of the oral cavity and orophar-
ynx by standard exfoliative cytology has proven unreliable
[11]. Without loss of minimal invasiveness, it is not possi-
ble to access the deeper cell layers of the oral cavity with
conventional exfoliative cytology [12].
The oral brush biopsy with computer-assisted analysis
is simple to perform, non-invasive, and has the potential
to overcome many of the obstacles that have hindered
early detection of early stage cancers and dysplasia [13].
In published studies in which oral lesions were subjected
to both brush biopsy and scalpel biopsy concomitantly,
the brush biopsy was found to have a sensitivity and a
specificity of greater than 90% in identifying dysplasia
and carcinoma [14,15].
Our aim was to evaluate computer-assisted analysis of
oral brush biopsies in a screening program that replicates
its use in an office setting of dentists and physicians. We
tested oral lesions that did not have an obvious etiology
and were minimally suspicious clinically, and compared
the results of brush biopsy with scalpel biopsy to deter-
mine the brush biopsy’s diagnostic accuracy and
usefulness.
Methods
Patients who were at least 18 years of age presenting with
unrelated complaints to the outpatient Department of
Otorhinolaryngology, Moti Lal Nehru Medical College in
Allahabad, were screened by a team of specialists and
residents-in-training between July and November 2010.
We obtained clearance from the Institutional ethics com-
mittee, and written consent was also granted by all
patients.
Patients with an oral epithelial abnormality that
appeared clinically benign- minimally suspicious- and did
not have an obvious etiology such as trauma or infection
were prospectively enrolled in the study (Figure 1). The
inclusion and exclusion criteria for patients enrolled in the
study are summarized in Table 1.
Demographic information of each patient was obtained
including the patients’ age, sex, and consumption of
tobacco and alcohol. With regard to tobacco consumption,
patients were classified non-users if they 1) reported no
use and 2) stopped tobacco use 10 or more years prior to
the study. We classified tobacco users as 1) persons who
stopped using tobacco less than 1 year prior to the study
and 2) ongoing users. Patients were considered alcohol
users if they consumed more than an average of 1 drink
per day for at least a year.
Prior to the examination, patients rinsed their mouth
thoroughly with water. The location, size and colour of
each lesion was ascertained from a thorough oral examina-
tion and documented. Every patient underwent a brush
biopsy and then a scalpel biopsy concomitantly at the
same visit.
Oral Brush Biopsy
A specially designed brush was used to obtain a transe-
pithelial specimen from all patients. The material from the
brush was spread on clean and dried glass slides, fixed
immediately, and sent for further processing to OralCDx
Laboratories
® (Suffern, New York, USA) where the results
were determined in a blinded fashion, independent of the
scalpel biopsy results. The brush biopsy results were classi-
fied into one of three categories as follows: “negative” -n o
epithelial abnormality; “atypical” - abnormal epithelial
changes; “positive” - definitive evidence of epithelial dys-
plasia or carcinoma. Using accepted reference standards
for cytologic evaluation, atypical and positive results are
considered abnormal as both warrant histologic analysis.
Patients with incomplete specimens- those that did not
demonstrate cells from all layers of the epithelium- were
excluded from the study and data analysis. Training of
investigators consisted of providing verbal instructions
and watching a brief training video for performing an oral
brush biopsy.
Scalpel biopsy
After the brush biopsy was performed, the same investiga-
tor performed a scalpel biopsy of the lesion and in the
same location tested with the brush biopsy. After routine
processing and paraffin embedding, several sections
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and Eosin and then examined by a pathologist in a blinded
fashion independent of the brush biopsy results.
In patients with discrepant oral brush biopsy and scal-
p e lb i o p s yr e s u l t s ,w ec o n f i r m e dt h ep r e s e n c eo ft h e
brush biopsy tissue defect in the histological specimen
of the scalpel biopsy. This ensured that the same part of
the lesion was indeed sampled by both the brush and
the scalpel instruments. (Figure 2)
Statistical confidence intervals (CI) were calculated
based on Student’s t-distribution and the exact binomial
Clopper-Pearson interval. Data analysis used the Mathe-
matica software package
® (Champaign, USA).
Results
Among 820 subjects consecutively screened, 85 patients
( M :F5 5 : 3 0 )w e r ef o u n dt oh a v eam i n i m a l l ys u s p i c i o u s -
appearing white or red spot that did not have an etiology.
The mean age at presentation was 45.5 with an overall
age range of 25 to 75 years. More than 50% of the 85
patients consumed either tobacco or alcohol or both.
The profile of the study patients are presented in Table 2.
The buccal mucosa was the most common site of
involvement accounting for just less than 50% of all
cases, followed by the tongue, alveolar mucosa and
gingivae.
The lesions demonstrated a wide range of clinical
characteristics and are presented in Table 3.
There were 6 patients (7%) with an inadequate brush
biopsy sample who were excluded from the study. The
results of 79 patients with matching and adequate brush
biopsy and scalpel biopsy samples were analyzed.
Of the 79 patients, 27 revealed histopathologic evi-
dence of dysplasia or carcinoma. The brush biopsy inde-
pendently detected all of these cases with the exception
of one patient with dysplasia. The sensitivity rate, defined
as a measure of the likelihood that a patient with dyspla-
sia or carcinoma will have an abnormal brush biopsy
result was 96.3% (26/27); 95% CI, 87%-100%. An addi-
tional 52 oral lesions, which were evaluated histologically,
did not reveal any features of dysplasia or carcinoma. Of
these, the brush biopsy reported 47 as “negative” with no
epithelial abnormalities and 5 as “atypical”. The specifi-
city rates, defined as a measure of the likelihood that a
patient with a benign lesion will have a “negative” result
is 100% (52/52) 95% CI, 93%-100% for “positive” brush
biopsy results and 90.4% (47/52) 95% CI, 82%-97% for
“atypical” brush biopsy results. The results of all oral
Figure 1 Clinical examples of minimally suspicious lesions sampled.
Table 1 Inclusion and exclusion criteria for patients enrolled in the study
Inclusion criteria Exclusion criteria
Patients with an oral epithelial abnormality that appeared clinically
benign- minimally suspicious- without any obvious etiology such as
trauma or infection.
Patients with medical issues and dental appliances such as orthodontic
or other fixed prostheses that could interfere with the examination were
excluded.
Multiple oral lesions. Oral lesions suggestive of dysplasia or cancer were excluded.
Patients with oral lesions that were either submucosal (i.e. cyst or salivary
gland tumor) or covered with a clinically intact normal epithelium (i.e.
hemangioma or fibroma).
Pigmented lesions such as nevi and amalgam tattoos as well as lip
lesions, specifically on the vermilion border or cutaneous surfaces,
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ized in Table 4.
Of the 79 patients, 31 had abnormal brush biopsy results
(Figure 3) and of these, histology from 26 cases was posi-
tive for either dysplasia or carcinoma. The positive predic-
tive value of an abnormal brush biopsy, defined as a
measure of the likelihood that a patient with an abnormal
brush biopsy will have a histologic report of dysplasia or
carcinoma on follow-up scalpel biopsy was 83.7% (26/31)
and the negative predictive value was 98% (47/48).
Discussion
In two recent review articles on oral cancer diagnostic
aids, Patton et al. [16] and Lingen et al. [17] concluded
that based upon published studies, oral brush biopsy with
computer-assisted analysis has been demonstrated to be
valuable for detecting dysplasia and cancer when evaluat-
ing “clinically suspicious” lesions. Both groups suggested
that the accuracy of the oral brush biopsy for testing
“minimally suspicious” lesions has not yet been estab-
lished. Our study indisputably demonstrates that the
brush biopsy is as sensitive and specific for evaluating
“minimally suspicious” l e s i o n sa sw e l la s“suspicious”
lesions and makes it an effective test to evaluate the entire
spectrum of lesions detected during an oral cancer screen-
ing examination.
The accuracy of the oral brush biopsy has been ques-
tioned by some authors who reported lower sensitivity and
specificity results compared to those reported in our study
[18-20] Purported oral brush biopsy “false-negative” or
“false positives” cases in the literature are not a reliable
comparison of the efficacy of the brush biopsy vs. the scal-
pel biopsy since these discrepant anecdotes, which have
been quoted repeatedly in the literature [16,17], are of
questionable value. In almost all cases, discrepant results
were reported from patients who had a scalpel biopsy and
brush biopsy performed at widely different times- often
months or over a year apart. Within a given oral lesion,
dysplasia is multicentric and therefore, unless the 2 biop-
sies test the same part of the dysplastic lesion by chance,
the results will often be discrepant. Furthermore, the bio-
l o g i cn a t u r eo fal e s i o nm a yc h a n g eo v e rt i m ea sb e n i g n
lesions may become dysplastic and dysplasia may also
regress [21]. Finally, the histologic diagnosis of dysplasia is
not easily reproduced amongst oral pathologists, with
poor intraobserver and interobserver variability in the
Figure 2 Histopathologic specimen demonstrating the oral
biopsy defect sampling the entire thickness of the epithelium.
(H &E x100).
Table 2 Profile of study patients (n = 85)
Sex ratio (M/F) 1/8:1 (55/30)
Age range: 25 - 75 (Mean: 45.5)
Tobacco use * 37 (44%)
Alcohol use ** 9 (11%) (8-21 drinks/week)
Both tobacco and alcohol 10 (12%)
*Tobacco users: 1) persons who stopped using tobacco less than 1 year prior
to the study and 2) ongoing users.
** Alcohol users: patients who consumed more than an average of 1 drink per
day for at least a year.
Table 3 Clinical characteristics of lesions tested by both
the brush biopsy and scalpel biopsy (n = 85)
Predominant Colour
White: 49
Red 18
Mixed 11
Not specified: 7
Location
Buccal mucosa 38
Tongue/Floor of mouth 18
Alveolar and labial mucosa 8
Gingiva 8
Hard palate 7
Site unspecified 6
Size
Less than 5 mm 45
5-10 mm 20
10-20 mm 3
>2 0m m 0
Not specified 17
Table 4 Results of brush biopsy and scalpel biopsy
N = 79 Scalpel Biopsy
Malignant or
Dysplastic
Scalpel
Biopsy
Benign
Total
Brush Biopsy Positive 1 0 1
Brush Biopsy Atypical 25 5 30
Brush Biopsy
Negative
14 7 4 8
Total 27 52 79
Sensitivity of brush biopsy: 96.3%; 95% CI, 87%-100%).
Specificity of “positive” brush biopsy result: 100%; 95% CI, 93%-100%
Specificity for “atypical” brush biopsy result: 90.4%; 95% CI, 82%-97%
Positive predictive value of an abnormal brush biopsy: 84%.
Negative predictive value of an abnormal brush biopsy value: 98%.
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result between brush biopsy and scalpel biopsy may also,
in fact, represent a false negative or false positive scalpel
biopsy result.
The limitations of comparing any two biopsy results
performed at different times are highlighted in a study of
200 patients with leukoplakia [24]. In this study, scalpel
biopsies were obtained from the same lesion at different
times, and the results showed an agreement rate between
two scalpel biopsies of only 56%. In another study by
Holmstrup et al [25], the degree of dysplasia in biopsies
from 101 oral lesions was compared with the results
from the entire specimen which was examined in step
sections, and the concurrent diagnosis was achieved in
only 49% of cases. As others have noted, when compari-
sons are made between any two biopsy techniques (i.e.
brush biopsy vs. scalpel biopsy or scalpel biopsy vs. scal-
pel biopsy), only studies comparing the results of both
biopsies performed at the same time and from the same
portion of the suspicious lesion should be considered
valid [26,27]. In the 3 studies in which an oral lesion was
simultaneously tested with both a brush biopsy and scal-
pel biopsy, including our study, the oral brush biopsy
with computer assistance has been shown to have a sen-
sitivity and specificity well over 90%.
For purposes of determining specificity, it is assumed
that when the brush biopsy detects dysplasia or cancer
which is not found on the scalpel biopsy, such cases are
classified as brush biopsy “false positives.” Although histol-
ogy is the standard for diagnosis, as with all anatomic
pathology laboratories, histologic sampling is not without
errors, and false positives as well as false negatives do
occur [28]. In our study, there were 5 patients whose
brush biopsies were abnormal and whose scalpel biopsies
were negative. It is possible that several cases of dysplasia
or cancer may have been missed with the scalpel biopsy.
Under ideal circumstances, these patients would be
recalled and a second scalpel biopsy would be performed.
Figure 3 Panorama of atypical and malignant cells identified from a brush biopsy specimen with the aid of a highly specialized
neural network-based image-processing system. (Pap × 1000).
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were performed concomitantly with the authors reporting
several brush biopsy false negatives in identifying dyspla-
sia, however, all cancers were identified with the brush
biopsy [20]. As the authors in that study point out, confir-
mation of a brush biopsy false negative result requires a
brush biopsy tissue defect to be present in the histological
specimen of the scalpel biopsy to ensure that the same
part of the lesion was sampled by both biopsies. Yet in
that study, not a single example of matched brush and
scalpel biopsies was presented for any of the purported
discrepant results. Therefore, a likely conclusion is that
different portions of the lesion may have been sampled.
Furthermore, surprisingly, 43 of the 69 lesions in that
study were presumably dysplastic and 15 were frank can-
cers, despite the fact that all of the lesions in the study
were not clinically suspicious. Bukhardt has analysed their
results and found some glaring problems supporting the
notion that the authors’ claim of finding dysplasia on
brush biopsy negative specimens likely represents false
positive histology results [29].
The high positive predictive value (PPV) of our study is
in agreement with 5 other studies published [14,15,
19,28,30] and contrasts with the results of a study by
Bhoopathi et al. who reported a low PPV [31]. In their
study, the authors claim that 3 “positive” brush biopsy spe-
cimens were negative on histology even though “positive”
brush biopsy cases always display cellular features pathog-
nomonic for dysplasia or carcinoma; therefore, it is doubt-
ful that these cases represent actual false positive brush
biopsy results.
The presence and number of basal cells in the brush
biopsy specimen, as detected by both the computer and
the examining pathologist, is the standard used by the
laboratory to determine the adequacy of the sample. In
other published clinical trials, incomplete brush biopsy
results with an insufficient basal cell count have been
reported between 2% and 7%. The incomplete rate in our
study was 7% and within the reported range of other stu-
dies. Our rate of incompletes could be due to the fact that
our study was conducted by residents-in-training. As their
experience with the technique improved, the number of
incomplete samples decreased.
The brush biopsy kits used in our study include both a
proprietary brush and an analysis with neural network
computer assistance of the specimens. Researchers, includ-
ing the author’s group, have attempted to use the brush
biopsy instrument without computer assistance [32], the
same brush in a liquid based preparation [33], a different
brush with analysis of specimens using computer assis-
tance [34], and a variety of so called instruments or “brush
biopsies” that collect a complete epithelial sample. When
subjected to studies, however, all of these proved to have
an unacceptably poor sensitivity and specificity. As
highlighted in many studies [14,35,36], the combination of
a transepithelial brush specimen and neural network ana-
lysis of that specimen are necessary to ensure an accurate
result.
The limitations of the current study include: (a) not
being able to recall and re-biopsy patients with abnormal
brush biopsies and negative scalpel biopsies to determine
if these represented false negative scalpel biopsy results;
and (b) “minimally suspicious” lesions which were
included in the study are highly subjective, and what may
appear to be suspicious to one observer may not be sus-
picious to others who examine the same lesion. Although
we did not calibrate the examiners as to which lesions
were minimally suspicious, the outcome of the study
would not likely to have changed; (c) since this study was
carried out in a location in India with a high prevalence
of oral lesions, the results should be evaluated with care.
Conclusion
All persistent white and red lesions that do not have an
obvious etiology such as trauma or infection require
evaluation- and not “watchful waiting”. Failure to con-
form to the standard of care, which requires all unex-
plained lesions to be evaluated, can have dire
consequences for both the patient and the oral care pro-
vider [37]. The results of our study, the first in the lit-
erature where matched oral brush and scalpel biopsies
were performed simultaneously on patients with mini-
mally suspicious oral lesions demonstrate that the com-
puter-assisted analysis of a brush biopsy is a highly
sensitive and specific, noninvasive test in the evaluation
of all oral lesions without an etiology. The test is espe-
cially beneficial when used on lesions that appear clini-
cally benign for identifying early stage cancers and
dysplasias - the lesions for which therapy is most effec-
tive. As an adjunct to oral cancer examination, its use
has the potential to reduce the poor mortality rate asso-
ciated with oral malignancies.
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